| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1478-3231.2007.01452.X |
| P698 | PubMed publication ID | 17403195 |
| P50 | author | John M. Luk | Q42935545 |
| P2093 | author name string | Sheung-Tat Fan | |
| Nikki P Lee | |||
| George K Lau | |||
| Pauline P Leung | |||
| Qi-Sheng Zhang | |||
| Kwok-Fan Cheung | |||
| Chee-Kin Hui | |||
| Ling-Xiao Liu | |||
| Mei-Yu Hu | |||
| Jana Y Wo | |||
| P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells | Q28374071 | ||
| Acrosome-specific gene AEP1: identification, characterization and roles in spermatogenesis | Q28567236 | ||
| Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy | Q33706858 | ||
| New treatment strategies in non-responder patients with chronic hepatitis C. | Q33809555 | ||
| Hepatic stellate cells as a target for the treatment of liver fibrosis | Q34391409 | ||
| Therapeutic basis of glycyrrhizin on chronic hepatitis B. | Q34394939 | ||
| Regulation of matrix metalloproteinases: an overview | Q35584927 | ||
| Albumin: biochemical properties and therapeutic potential | Q36138540 | ||
| Resection and liver transplantation for hepatocellular carcinoma. | Q36140302 | ||
| The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis | Q36253127 | ||
| Endocytosis mediated by monocyte and macrophage membrane lectins--application to antiviral drug targeting | Q37926378 | ||
| 18 Beta-glycyrrhetinic acid triggers curative Th1 response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-kappa B. | Q40400399 | ||
| Regulatory role of vHL/HIF-1alpha in hypoxia-induced VEGF production in hepatic stellate cells. | Q40570292 | ||
| Regulation of soluble insulin-like growth factor-II/mannose 6-phosphate receptor in hepatocytes from intact and regenerating rat liver | Q41930277 | ||
| TNP-470 blockage of VEGF synthesis is dependent on MAPK/COX-2 signaling pathway in PDGF-BB-activated hepatic stellate cells. | Q42168735 | ||
| Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats | Q43720079 | ||
| Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA). | Q43758756 | ||
| Hepatocyte growth factor gene therapy of liver cirrhosis in rats | Q44406096 | ||
| Synthesis of a targeting drug for antifibrosis of liver; a conjugate for delivering glycyrrhetin to hepatic stellate cells | Q44715294 | ||
| Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis. | Q44825219 | ||
| Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats | Q45212257 | ||
| Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models | Q46693145 | ||
| The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo. | Q46913710 | ||
| Expression of hepatocyte-like phenotypes in bone marrow stromal cells after HGF induction | Q47234876 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 548-557 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Liver International | Q15765078 |
| P1476 | title | Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model | |
| P478 | volume | 27 |
| Q36577152 | 18α-Glycyrrhizin induces apoptosis and suppresses activation of rat hepatic stellate cells |
| Q44044385 | 18β-glycyrrhetinic acid inhibits hepatocellular carcinoma development by reversing hepatic stellate cell-mediated immunosuppression in mice |
| Q37043515 | Bioconjugation of oligonucleotides for treating liver fibrosis |
| Q37317654 | Current and future anti-fibrotic therapies for chronic liver disease |
| Q55602514 | Glycyrrhetinic acid-poly(ethylene glycol)-glycyrrhetinic acid tri-block conjugates based self-assembled micelles for hepatic targeted delivery of poorly water soluble drug. |
| Q42919316 | Insight into glycyrrhetinic acid: The role of the hydroxyl group on liver targeting |
| Q39022995 | Involvement of BID translocation in glycyrrhetinic acid and 11-deoxy glycyrrhetinic acid-induced attenuation of gastric cancer growth |
| Q42653645 | Laparoscopic surgery induced interleukin-6 levels in serum and gut mucosa: implications of peritoneum integrity and gas factors. |
| Q37066021 | Mannose 6-phosphate receptor targeting and its applications in human diseases |
| Q51000204 | Pharmacokinetics and Biodistribution of GDC-0449 Loaded Micelles in Normal and Liver Fibrotic Mice. |
| Q26768588 | Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis |
| Q26781325 | Potential Use of Biological Proteins for Liver Failure Therapy |
| Q27003833 | Potential role of thymosin Beta 4 in liver fibrosis |
| Q35020230 | Preventative effect of Astragalus flavescens on hepatic fibrosis in rats and its mechanism of action |
| Q90118163 | Research progress on the protective effects of licorice-derived 18β-glycyrrhetinic acid against liver injury |
| Q27000074 | Therapeutic targeting of liver inflammation and fibrosis by nanomedicine |
| Q36909491 | Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation. |
Search more.